News

New Team members

Imavita is proud to announce New Team members with the recent recruitment of Maud Chusseau and Julia Rochotte. Maud Chusseau, MSc, Research Scientist, Maud is graduated from University

Best wishes for 2019 from Imavita’s team

All the team of Imavita wishes to all collaborators, colleagues, customers and suppliers and their families, an excellent and happy new year 2019!

Imavita, partner in Pi-R2 project / Radio-fluorination platform

IMAVITA S.A.S., an innovating technology company providing services in preclinical models of human pathologies associated with imaging and image analysis, announces its participation in the collaborative project Pi-R2

Imavita, partenaire du projet PiR2

IMAVITA S.A.S., société de services et d’innovation dans les modèles précliniques de pathologies humaines associées à l’imagerie et l’analyse d’images, annonce sa participation au projet collaboratif PiR2 /

Release of in vivo OCT imaging in preclinical models

Imavita released the use of OCT (Optical Coherence Tomography) for in vivo imaging in the following applications: Dermatology Atopic dermatitis / Oxazolone & IL23 models Psoriasis / IMQ

Innovating imaging of dermatology models

Imavita is proud to announce the acquisition of new Optical Coherence Tomography apparatus to develop Innovating imaging of dermatology models. Since september 2017, Imavita is working on this

Imavita laboratories address moved

Since January 2nd 2017, Imavita laboratories address moved to Canal Biotech 1, 3 rue des Satellites, 31400 Toulouse, France. This address will be the same for headquarters. The

The team is growing

Team is growing! Imavita is proud to announce the recent recruitment of Elisabeth Bonnard and Jeanne Chapel. Dr Elisabeth Bonnard, Neuropharmacologist, PhD, Project Leader, was graduated on 2004

New imaging resources

Imavita is proud to announce the acquisition of new Fluorescence Molecular Tomography imaging apparatus for the evaluation of its models. Since october 2016, a Fluorescence Tomography system was